Addex Therapeutics Ltd (FRA:APE)

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 36.38K CHF in the quarter ending June 30, 2025, a decrease of -68.45%. This brings the company's revenue in the last twelve months to 55.35K, down -93.33% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 404.10K, down -74.95%.

• Revenue (ttm): 55.35K CHF
• Revenue Growth: -93.33%
• P/S Ratio: 38.47
• Revenue / Employee: 27.67K CHF
• Employees: 2
• Market Cap: 6.89M EUR

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	404.10K	-1.21M	-74.95%
Dec 31, 2023	1.61M	190.52K	13.39%
Dec 31, 2022	1.42M	-1.49M	-51.22%
Dec 31, 2021	2.92M	-696.51K	-19.28%
Dec 31, 2020	3.61M	849.99K	30.77%
Dec 31, 2019	2.76M	-3.28M	-54.29%
Dec 31, 2018	6.04M	5.54M	1,109.03%
Dec 31, 2017	499.89K	214.80K	75.35%
Dec 31, 2016	285.09K	-30.61K	-9.70%
Dec 31, 2015	315.70K	7.92K	2.57%
Dec 31, 2014	307.78K	165.69K	116.61%
Dec 31, 2013	142.09K	21.00K	17.34%
Dec 31, 2012	121.09K	-2.70M	-95.71%
Dec 31, 2011	2.82M	848.18K	42.94%
Dec 31, 2010	1.98M	-2.12M	-51.71%
Dec 31, 2009	4.09M	-22.72M	-84.74%
Dec 31, 2008	26.81M	26.32M	5,405.31%
Dec 31, 2007	486.93K	-4.25M	-89.73%
Dec 31, 2006	4.74M	-	-